Anheuser-Busch InBev SA/NV (EBR:ABI)

Aerovate Therapeutics Revenue

Anheuser-Busch InBev had revenue of $15.00B USD in the quarter ending June 30, 2025, a decrease of -2.15%. This brings the company's revenue in the last twelve months to $58.52B, down -2.35% year-over-year. In the year 2024, Anheuser-Busch InBev had annual revenue of $59.77B with 0.65% growth.

• Revenue (ttm): $58.52B
• Revenue Growth: -2.35%
• P/S Ratio: 2.04
• Revenue / Employee: $406.71K
• Employees: 143,885
• Market Cap: 101.54B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	59.77B	388.00M	0.65%
Dec 31, 2023	59.38B	1.59B	2.76%
Dec 31, 2022	57.79B	3.48B	6.41%
Dec 31, 2021	54.30B	7.42B	15.83%
Dec 31, 2020	46.88B	-5.45B	-10.41%